Modern Diagnostic IPO
Market Sentiment
Market Lot Size
IPO Details
IPO Reservation
Financial Analysis
| Metric | 2023 | 2024 | 2025 | June 2025 |
|---|---|---|---|---|
| Revenue | 56.61 | 68.67 | 78.80 | 22.67 |
| Expense | 62.55 | 61.81 | 66.08 | 18.40 |
| Profit (PAT) | 5.73 | 5.79 | 8.97 | 3.00 |
| Total Assets | 36.54 | 49.49 | 64.57 | 77.86 |
Promoters: Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 1,10,00,000 | 99.99% |
| Promoter Holding Post Issue | 1,50,99,200 | 72.85% |
Company Information
Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India. The company offers a complete range of diagnostic facilities in radiology and pathology. Modern Diagnostic is involved in providing healthcare tests and services for diagnosis for individual patients, hospitals, healthcare providers, and corporate clients. The company offers many diagnostic services in radiology and pathology, such as ultrasound and colour doppler, CT scan, MRI, digital X-ray, mammography, heart lab, neuro lab, laboratory tests, ECG, CBCT, OPG, PFT, and more. They also provide services like home sample collection, where they visit the patients to take the blood sample who are unable to visit the centre. Moreover, the company currently runs 21 centers, 17 labs, and 4 diagnostic centers across 8 states.
| Purpose | Amount (Cr) |
|---|---|
| Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories | 20.69 |
| Funding Working Capital Requirement | 11.60 |
| Repayment of certain outstanding borrowings availed by the Company | 4.50 |
| General Corporate Purpose | - |
Resources & Documents
Modern Diagnostic & Research Centre Limited., Plot No H-64,1st Floor BLK-H, Bali, Nagar City landmark near Khetar Pal, Hospital, Ramesh Nagar, West Delhi,, New Delhi, Delhi-110015, India, Email Id: [email protected]
Modern Diagnostic has set a price band of Rs 85–Rs 90 per share for an issue size of Rs 37 crore. The stock listed with a 10.56% gain versus its issue price on January 07, 2026.
Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India. The company offers a complete range of diagnostic facilities in radiology and pathology.
The issue is promoted by Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh with Beeline Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories (Rs 21 crore) and Funding Working Capital Requirement (Rs 12 crore).
Grey market is quoting a premium of +Rs 14 (+15.6% over issue price). Final subscription data records overall subscription at 376.97x, retail at 342.46x, QIB at 193.51x, NII at 702.43x.
On fundamentals, the company is posting revenue growth of 14.8%, a profit margin of 11.4%, return on equity of 55.2% in its most recent reported period. Listed peers in this segment include Vijaya Diagnostic Centre Limited (P/E 72.36x, market cap Rs 18 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
Our data-driven engine currently flags this issue as a Subscribe call — the composite picture tilts favourable, though not without some caveats. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Understanding Grey Market Premium (GMP)
The Grey Market Premium (GMP) is an unofficial indicator of how an IPO's shares are trading in the grey market before they are officially listed on a stock exchange. It reflects investor sentiment and demand for the IPO shares ahead of listing day.
How does it work? The grey market is an informal, over-the-counter market where investors buy and sell IPO shares before the official listing date. If an IPO has a positive GMP, it suggests that investors expect the stock to list above its issue price. A negative GMP indicates expectations of a listing below the issue price.
Example: If an IPO has an issue price of ₹100 and the GMP is ₹50, the expected listing price would be approximately ₹150 (issue price + GMP). This translates to an estimated listing gain of 50%.
Factors that influence GMP:
- Subscription levels — Higher subscription typically drives GMP up
- Market conditions — Bullish markets tend to boost GMP across all IPOs
- Company fundamentals — Strong financials and growth potential attract premium
- Industry sentiment — Positive outlook for the sector can increase demand
- IPO pricing — Reasonably priced IPOs relative to peers tend to command higher GMP
Disclaimer: GMP is an unofficial metric from the grey market and is not regulated by SEBI or any stock exchange. GMP values fluctuate frequently and should not be the sole basis for investment decisions. Always consider company fundamentals, financial health, and your own risk appetite before investing in any IPO.
Related IPO
No comments yet. Be the first to share your opinion!